Article Text

other Versions

PDF
A novel mutation in transforming growth factor-beta induced protein (TGFβIp) reveals secondary structure perturbation in lattice corneal dystrophy
  1. Rajamani Lakshminarayanan1,
  2. Eranga N Vithana1,2,
  3. Shu-Ming Chai1,3,
  4. Shyam S Chaurasia1,
  5. Padhmanaban Saraswathi1,
  6. Anandalaksmi Venkatraman1,
  7. Camille Rojare1,
  8. Divya Venkataraman1,
  9. Donald Tan1,2,3,
  10. Tin Aung1,2,3,
  11. Roger W Beuerman1,2,4,
  12. Jodhbir S Mehta1,2,3,4
  1. 1Singapore Eye Research Institute, Singapore
  2. 2Department of Ophthalmology, Yong Loo Lin School of Medicine, National University of Singapore
  3. 3Singapore National Eye Centre, Singapore
  4. 4Department of Clinical Sciences, Duke-NUS Graduate Medical School, Singapore
  1. Correspondence to Professor Jodhbir S Mehta, Singapore National Eye Centre, 11 Third Hospital Avenue, Singapore 168751, Singapore; jodmehta{at}gmail.com

Abstract

Background To describe mutations in the transforming growth factor-beta induced (TGFBI) gene in Asian patients with Bowman's membrane as well as stromal corneal dystrophies, and to elucidate their structural implications, using model peptides.

Methods Twenty-two unrelated Asian families were examined clinically including visual acuity testing and ocular examination with slit lamp biomicroscopy. Genomic DNA was extracted and the 17 exons of the TGFBI gene were amplified by PCR and sequenced bi-directionally. Biophysical techniques were used to characterise the wild type and mutant model peptides.

Results Molecular genetic analysis identified a variety of mutations in our patient series including a novel heterozygous C to A transversion mutation in exon 14 (c.1859C→A), resulting in a substitution of a highly conserved alanine residue by aspartic acid (p.A620D). Clinical presentation in the patient with the p.A620D included subepithelial scarring in addition to the linear branching opacities usually seen with lattice dystrophy. Using model peptides, we showed that A620D mutant peptide alters the secondary structure and conformational stability, and increased amyloid formation.

Conclusion A novel mutation (A620D) in transforming growth factor-beta induced protein (TGFβIp) is described, expanding the repertoire of mutations in this protein. Using model peptides, we demonstrated that A→D substitution leads to perturbation of the secondary structure that may be responsible for the amyloid formation in lattice corneal dystrophy.

  • Cornea
  • lattice corneal dystrophy
  • TGFBI
  • amyloid
  • conformational stability
  • experimental and 8211 animal models
  • genetics
  • imaging
  • treatment lasers
  • clinical trial
  • experimental and 8211 laboratory

Statistics from Altmetric.com

Footnotes

  • Competing interests None to declare.

  • Patient consent Obtained.

  • Ethics approval Institutional Review Board, Singapore National Eye Centre, Singapore. All parts of the study were performed according to the tenets of the Declaration of Helsinki.

  • Provenance and peer review Not commissioned; externally peer reviewed.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.